Extracellular vesicles and their nucleic acids for biomarker discovery

被引:84
|
作者
Momen-Heravi, Fatemeh [1 ,2 ]
Getting, Stephen J. [2 ,3 ]
Moschos, Sterghios Athanasios [2 ,4 ]
机构
[1] Columbia Univ, Coll Dent Med, Sect Oral & Diagnost Sci, Div Periodont, New York, NY USA
[2] Univ Westminster, Dept Biomed Sci, London, England
[3] Univ Westminster, Dept Life Sci, London, England
[4] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle, England
关键词
Biomarker; DNA; Extracellular vesicles; Exosomes; Nucleic acids; RNA; TUMOR-DERIVED EXOSOMES; DOUBLE-STRANDED DNA; CIRCULATING MICRORNAS; MESSENGER-RNA; EMERGING ROLE; INTERCELLULAR TRANSFER; POTENTIAL BIOMARKERS; MEMBRANE-VESICLES; MEDIATED TRANSFER; URINARY EXOSOMES;
D O I
10.1016/j.pharmthera.2018.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extracellular vesicles (EVs) are a heterogenous population of vesicles originate from cells. EVs are found in different biofluids and carry different macromolecules, including proteins, lipids, and nucleic acids, providing a snap shot of the parental cells at the time of release. EVs have the ability to transfer molecular cargoes to other cells and can initiate different physiological and pathological processes. Mounting lines of evidence demonstrated that EVs' cargo and machinery is affected in disease states, positioning EVs as potential sources for the discovery of novel biomarkers. In this review, we demonstrate a conceptual overview of the EV field with particular focus on their nucleic acid cargoes. Current knowledge of EV subtypes, nucleic acid cargo and pathophysiological roles are outlined, with emphasis placed on advantages against competing analytes. We review the utility of EVs and their nucleic acid cargoes as biomarkers and critically assess the newly available advances in the field of EV biomarkers and high throughput technologies. Challenges to achieving the diagnostic potential of EVs, including sample handling, EV isolation, methodological considerations, and bioassay reproducibility are discussed. Future implementation of 'omics-based technologies and integration of systems biology approaches for the development of EV-based biomarkers and personalized medicine are also considered. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:170 / 187
页数:18
相关论文
共 50 条
  • [21] Isolation and characterization of extracellular vesicles in faecal matter: implications for future biomarker discovery
    Leal-Lassalle, Hector
    Estevez-Vazquez, Olga
    Benede-Ubieto, Raquel
    Castillo-Gonzalez, Raquel
    Sancho-Temino, Lucia
    Cruz-Adalia, Aranzazu
    Banares, Rafael
    Vaquero, Javier
    Cubero, Francisco Javier
    Nevzorova, Yulia
    JOURNAL OF HEPATOLOGY, 2024, 80 : S276 - S277
  • [22] Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery
    Kato, Chris
    Ueda, Koji
    Morimoto, Satoru
    Takahashi, Shinichi
    Nakamura, Shiho
    Ozawa, Fumiko
    Ito, Daisuke
    Date, Yugaku
    Okada, Kensuke
    Kobayashi, Naoki
    Nakahara, Jin
    Okano, Hideyuki
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [23] Enrichment of plasma extracellular vesicles for reliable quantification of their size and concentration for biomarker discovery
    Holcar, Marija
    Ferdin, Jana
    Sitar, Simona
    Tusek-Znidaric, Magda
    Dolzan, Vita
    Plemenitas, Ana
    Zagar, Ema
    Lenassi, Metka
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [24] Exploring the biological roles of extracellular vesicles carrying nucleic acids in ovarian cancer
    Yokoi, Akira
    CANCER SCIENCE, 2021, 112 : 204 - 204
  • [25] Comprehensive analyses of small extracellular vesicles carrying nucleic acids in ovarian cancer
    Yokoi, Akira
    Ochiya, Takahiro
    CANCER SCIENCE, 2021, 112 : 973 - 973
  • [26] Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
    Nawaz, Muhammad
    Fatima, Farah
    Nazarenko, Irina
    Ekstrom, Karin
    Murtaza, Iram
    Anees, Mariam
    Sultan, Aneesa
    Neder, Luciano
    Camussi, Giovanni
    Valadi, Hadi
    Squire, Jeremy A.
    Kislinger, Thomas
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (04) : 395 - 409
  • [27] Enrichment of plasma extracellular vesicles for reliable quantification of their size and concentration for biomarker discovery
    Marija Holcar
    Jana Ferdin
    Simona Sitar
    Magda Tušek-Žnidarič
    Vita Dolžan
    Ana Plemenitaš
    Ema Žagar
    Metka Lenassi
    Scientific Reports, 10
  • [28] UTILIZATION OF TUMOR-DERIVED EXTRACELLULAR VESICLES FOR PATIENT STRATIFICATION AND BIOMARKER DISCOVERY
    Havranek, Katie
    Seibold, Claire
    Seibold, Tia
    Kinnersley, Margie
    Van Vaerenberghe, Kelley
    Blohm, Tre
    Short-Miller, Rachel
    Lodmell, Sean
    Mast, Amanda
    Kemp, Riley
    NEURO-ONCOLOGY, 2024, 26
  • [29] TRANSCRIPTOMIC ANALYSIS OF EXTRACELLULAR VESICLES FOR BIOMARKER DISCOVERY IN PERIPHERAL ARTERY DISEASE (PAD)
    Saenz De Pipaon, G.
    David, L.
    Maillo, A.
    Vilas, A.
    Planell, N.
    Rodriguez, J. A.
    San Martin, P.
    Paramo, J. A.
    Prosper, F.
    Orbe, J.
    Gomez-Cabrero, D.
    Roncal, C.
    ATHEROSCLEROSIS, 2019, 287 : E65 - E65
  • [30] Nucleic acid delivery with extracellular vesicles
    Schulz-Siegmund, Michaela
    Aigner, Achim
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 173 : 89 - 111